Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tiragolumab × Gynecologic × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8 Gastrointestinal 5 Genitourinary 3 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 CNS 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 57 pembrolizumab 51 Carboplatin 45 Specimen Handling 41 Bevacizumab 41 olaparib 33 Magnetic Resonance Spectroscopy 30 Biopsy 27 Cisplatin 21 Gemcitabine 18 Taxes 16 Cyclophosphamide 15 Doxorubicin 14 liposomal doxorubicin 13 lenvatinib 11 Nivolumab 11 niraparib 10 fludarabine 10 Letrozole 10 Fulvestrant 10 Drug Therapy 10 dostarlimab 9 Topotecan 9 Radiotherapy 9 Immunoglobulin G 9 Docetaxel 9 durvalumab 8 atezolizumab 8 X-Rays 8 trastuzumab deruxtecan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300647 2026-03-12

SKYSCRAPER-04

Hoffmann-La Roche

Phase 2 Completed

172 enrolled 27 charts

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡